Group A: ACT subsidy and RDT subsidy N=116 | Group B: RDT subsidy N=107 | Group C: ACT subsidy N=114 | Group D: no subsidy (reference) N=107 | Total N=444 | |
---|---|---|---|---|---|
% | % | % | % | % | |
Had a malaria test* | 73.7 (n=84) | 73.8 (n=76) | 49.6 (n=56) | 51.0 (n=51) | 62.1 (n=267) |
Positive | 39.3 (n=33) | 27.6 (n=21) | 44.6 (n=25) | 47.1 (n=24) | 38.6 (n=103) |
No ACT | 18.2 | 28.6 | 16.0 | 41.7 | 25.2 |
ACT | 81.8 | 71.4 | 84.0 | 58.3 | 74.8 |
Negative | 60.7 (n=51) | 72.4 (n=55) | 55.4 (n=31) | 52.9 (n=27) | 61.4 (n=164) |
No ACT | 72.5 | 80.0 | 87.1 | 92.6 | 81.1 |
ACT | 27.5 | 20.0 | 12.9 | 7.4 | 18.9 |
Appropriate ACT use† | 76.2 (n=84) | 77.6 (n=76) | 85.7 (n=56) | 76.5 (n=51) | 78.7 (n=267) |
Did not have a test | 26.3 (n=30) | 26.2 (n=27) | 50.4 (n=57) | 49.0 (n=49) | 37.9 (n=163) |
No ACT | 70.0 | 70.4 | 78.9 | 73.5 | 74.2 |
ACT | 30.0 | 29.6 | 21.1 | 26.5 | 25.8 |
Targeted ACT use‡ | 56.1 (n=116) | 57.3 (n=107) | 42.5 (n=114) | 39.0 (n=107) | 48.8 (n=444) |
Observations | N=114 | N=103 | N=113 | N=100 | N=430 |
*Self-report of any malaria test (RDT or slide) at health facility or tested by the CHW.
†Defined as taking ACT if positive or not taking ACT if negative among those who had a malaria test.
‡Defined as taking ACT if positive or not taking ACT if negative among all participants.
ACT, artemisinin combination therapy; RDT, rapid diagnostic test.